SCHEMBL3702162

SCHEMBL3702162

O=C(O)C(CS)NI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14190836 1.00
SCHEMBL29429809 1.00
SCHEMBL31650803 0.80
SCHEMBL20672987 0.79
SCHEMBL29596626 0.78 KDM4E (0.58)
SCHEMBL17826675 0.77
SCHEMBL19152276 0.77
SCHEMBL22028100 0.77
SCHEMBL3456469 0.76
SCHEMBL3456466 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2154979-A1 HURDLE TECHNOLOGY FOR PROUCING SHELF-STABLE GUACAMOLE Frito-Lay North America, Inc. (US) 2010-02-24 EP claimed
WO-2008134152-A1 HURDLE TECHNOLOGY FOR PROUCING SHELF-STABLE GUACAMOLE FRITO-LAY NORTH AMERICA, INC. (US) 2008-11-06 WO claimed
WO-2023081980-A1 BACTERIAL STRAINS FOR TREATING DISEASE MICROBA IP PTY LTD (AU) 2023-05-19 WO disclosed
WO-2017132459-A1 DNA ALKYLATION AND CROSS-LINKING AGENTS AS COMPOUNDS AND PAYLOADS FOR TARGETED THERAPIES YALE UNIVERSITY (US) 2017-08-03 WO disclosed
EP-3052617-A1 REPROGRAMMING OF PLURIPOTENT STEM CELLS FOR IMPROVED CONTROL OF THEIR DIFFERENTIATION PATHWAYS ETH Zurich (CH) 2016-08-10 EP disclosed
US-20160015835-A1 LUCIFERIN DERIVATIVES FROM BICYCLIC REACTANTS AND AMINOTHIOL DERIVATIVES AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-01-21 US disclosed
US-9173966-B2 Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-11-03 US disclosed
WO-2015049342-A1 REPROGRAMMING OF PLURIPOTENT STEM CELLS FOR IMPROVED CONTROL OF THEIR DIFFERENTIATION PATHWAYS ETH ZURICH (CH) 2015-04-09 WO disclosed
US-20130287699-A1 Luciferin Derivatives from Bicyclic Reactants and Aminothiol Derivatives and Methods of Use Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2013-10-31 US disclosed
WO-2004015391-A9 MASS SPECTROMETRY-BASED IDENTIFICATION OF PROTEINS CORNELL RES FOUNDATION INC (US) 2004-07-22 WO disclosed
EP-0676964-A1 NITROSYLATION OF PROTEIN SH GROUPS AND AMINO ACID RESIDUES AS A THERAPEUTIC MODALITY BRIGHAM AND WOMEN'S HOSPITAL (US) 1995-10-18 EP disclosed
EP-0676964-A4 NITROSYLATION OF PROTEIN SH GROUPS AND AMINO ACID RESIDUES AS A THERAPEUTIC MODALITY. BRIGHAM & WOMENS HOSPITAL (US) 1995-08-10 EP disclosed
WO-1993009806-A1 NITROSYLATION OF PROTEIN SH GROUPS AND AMINO ACID RESIDUES AS A THERAPEUTIC MODALITY BRIGHAM AND WOMEN'S HOSPITAL (US) 1993-05-27 WO disclosed